Namely, the reduction in ESKD-HD patients affected naïve/middle aged cells (CD8+CD31+, CD8+CD45RA+CD28+, CD8+CD28+CD57−, CD8+CD45RA+CD57−) and is describe at Table 4. The gene discussed is CD28; the disease is Huntington disease.